Asthma: all 4,012 studies

Page 8 of 41. Open to participants first (515), then studies with results posted, then the rest; newest registration first within each.

• A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban ChildrenCompletedNCT03292588Phase 2Results posted
• Pilot of Lifestyle and Asthma InterventionCompletedNCT03291808Not applicableResults posted
• First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate AsthmaCompletedNCT03287310Phase 1Results posted
• Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 YearsCompletedNCT03273946Results posted
• physicAl aCtiviTy In minOrity womeN With Asthma InterventionCompletedNCT03265665Not applicableResults posted
• Pneumococcal Vaccines in Patients With AsthmaCompletedNCT03260790Phase 4Results posted
• Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.CompletedNCT03257995Phase 2Results posted
• Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With AsthmaCompletedNCT03248128Phase 3Results posted
• Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled AsthmaCompletedNCT03226392Phase 3Results posted
• Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled AsthmaCompletedNCT03215758Phase 3Results posted
• Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe AsthmaCompletedNCT03207243Phase 2Results posted
• Specific Use-Result of Spiriva Respimat® in AsthmaticsCompletedNCT03188120Results posted
• Investigation of the Role of Pictorial Asthma Action Plans to Promote Self-management in Rural Youth With AsthmaCompletedNCT03187119Not applicableResults posted
• Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)CompletedNCT03186209Phase 3Results posted
• A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With AsthmaCompletedNCT03184987Phase 3Results posted
• Asthma in Families Facing Out-of-pocket Requirements With DeductiblesCompletedNCT03175536Results posted
• A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.CompletedNCT03170271Phase 3Results posted
• Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + TiotropiumCompletedNCT03158311Phase 3Results posted
• Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in AsthmaCompletedNCT03137784Phase 2/3Results posted
• Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)CompletedNCT03137303Phase 3Results posted
• BI 443651 Methacholine ChallengeCompletedNCT03135899Phase 1Results posted
• Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With AsthmaCompletedNCT03108027Phase 2Results posted
• A Long-term Safety Study of QVM149 in Japanese Patients With AsthmaCompletedNCT03100825Phase 3Results posted
• A Long-term Safety Study of QMF149 in Japanese Participants With AsthmaCompletedNCT03100500Phase 3Results posted
• Study of Mepolizumab Autoinjector in AsthmaticsCompletedNCT03099096Phase 3Results posted
• A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)CompletedNCT03086460Phase 2Results posted
• An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic SubjectsCompletedNCT03084718Phase 2Results posted
• Health Effects of Secondhand Smoke Exposure in Outdoor Smoking Areas in Patients With COPD and Asthma ( TackSHSWP5 )CompletedNCT03074734Not applicableResults posted
• Breathing Counts: Evaluating Adherence in the Presence of Asthma Navigation SupportCompletedNCT03065205Not applicableResults posted
• Assess Bronchodilator Effect and Safety of Two Doses of QVM149 Compared to a Fixed Dose Combination of Salmeterol/Fluticasone in Patients With Asthma.CompletedNCT03063086Phase 2Results posted
• A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaTerminatedNCT03052725Phase 3Results posted
• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma TreatmentTerminatedNCT03052517Phase 3Results posted
• Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 in Healthy Participants Who Smoke CigarettesCompletedNCT03045887Phase 1Results posted
• Feasibility of the BREATHE Asthma Intervention TrialCompletedNCT03036267Not applicableResults posted
• Aligning With Schools To Help Manage Asthma (Project ASTHMA)CompletedNCT03032744Not applicableResults posted
• Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma DisparitiesCompletedNCT03032159Not applicableResults posted
• Effectiveness of the Aeroneb in Acute Severe AsthmaCompletedNCT03029156Not applicableResults posted
• Study of Mepolizumab Safety Syringe in AsthmaticsCompletedNCT03021304Phase 3Results posted
• Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled AsthmaCompletedNCT03015610Phase 3Results posted
• Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic PatientsCompletedNCT03015259Phase 3Results posted
• Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With AsthmaCompletedNCT03012061Phase 2Results posted
• Interventions To Help Asthma Clinical AdherenceCompletedNCT02999789Not applicableResults posted
• Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma REliefCompletedNCT02995733Phase 4Results posted
• iTRACC (Improving Technology-Assisted Recording of Asthma Control in Children)CompletedNCT02994238Not applicableResults posted
• Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic SubjectsCompletedNCT02991859Phase 2Results posted
• Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder InhalerCompletedNCT02980133Phase 3Results posted
• A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With AsthmaCompletedNCT02969408Phase 3Results posted
• Influenza Vaccine Feasibility Study in Children With Persistent AsthmaCompletedNCT02967393Phase 4Results posted
• Evaluation of Dupilumab in Children With Uncontrolled AsthmaCompletedNCT02948959Phase 3Results posted
• An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway InflammationTerminatedNCT02937168Phase 4Results posted
• A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled AsthmaCompletedNCT02924688Phase 3Results posted
• Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at HomeCompletedNCT02918071Phase 3Results posted
• A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe AsthmaCompletedNCT02918019Phase 2Results posted
• Childhood Asthma Management in Primary Care: Implementation Of Exhaled Nitric Oxide and Spirometry TestingCompletedNCT02913872Results posted
• A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled AsthmaTerminatedNCT02902809Phase 3Results posted
• AZD1419 Ph2a StudyCompletedNCT02898662Phase 2Results posted
• Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With AsthmaCompletedNCT02892019Phase 2Results posted
• Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a YearCompletedNCT02889809Phase 4Results posted
• A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic InflammationCompletedNCT02869438Phase 3Results posted
• Asthma Control Test Guided Treatment in Chinese SubjectsCompletedNCT02868281Phase 4Results posted
• Safety of Nasal Influenza Immunisation in Children With AsthmaCompletedNCT02866942Phase 4Results posted
• Effect of the GSK2245035 on the Allergen-induced Asthmatic ResponseCompletedNCT02833974Phase 2Results posted
• Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe AsthmaCompletedNCT02814643Phase 3Results posted
• Treating Caregiver Depression to Improve Childhood Asthma: Impact and MediatorsCompletedNCT02809677Not applicableResults posted
• A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 AgonistCompletedNCT02808819Phase 3Results posted
• Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)CompletedNCT02805907Phase 4Results posted
• Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct UseCompletedNCT02794480Phase 4Results posted
• Validation of the Hospital Asthma Severity Score (HASS)CompletedNCT02782065Results posted
• A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With AsthmaCompletedNCT02777827Phase 1Results posted
• Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma PatientCompletedNCT02774941Not applicableResults posted
• Heart Rate Variability Biofeedback: It's Role in Asthma TherapeuticsCompletedNCT02766374Not applicableResults posted
• Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and AsthmaCompletedNCT02761252Phase 4Results posted
• Telemedicine Enhanced Asthma Management Through the Emergency DepartmentCompletedNCT02752165Not applicableResults posted
• Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)CompletedNCT02741271Phase 3Results posted
• Biomarkers of Irritant-Induced and Allergic AsthmaCompletedNCT02740543Phase 2Results posted
• In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe AsthmaCompletedNCT02740049Early Phase 1Results posted
• Improving Asthma Care by Partnering With School Nurses to Bring Asthma Care Into the Inner-City SchoolsCompletedNCT02735174Not applicableResults posted
• Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)CompletedNCT02730351Phase 4Results posted
• Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma ExacerbationCompletedNCT02725008Phase 3Results posted
• Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)CompletedNCT02720081Phase 2Results posted
• A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.CompletedNCT02712047Phase 2Results posted
• Cockroach Nasal Allergen Challenge PilotCompletedNCT02710136Phase 1Results posted
• Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in AsthmaCompletedNCT02703467Results posted
• PEEP as Rescue Therapy for Asthmatics With Elevated BMICompletedNCT02696980Phase 1/2Results posted
• Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)TerminatedNCT02687815Phase 2Results posted
• TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)CompletedNCT02676089Phase 3Results posted
• TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABACompletedNCT02676076Phase 3Results posted
• Exacerbations in Severe Asthma Patients: Mechanisms and BiomarkersCompletedNCT02660853Not applicableResults posted
• Effect of OC459 on the Response to Rhinovirus Challenge in AsthmaCompletedNCT02660489Phase 2Results posted
• Sputum-derived Cellular Targets After Xolair (Omalizumab)TerminatedNCT02658877Phase 4Results posted
• Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma PatientsCompletedNCT02654145Phase 4Results posted
• Asthma Controller Adherence After HospitalizationCompletedNCT02615743Not applicableResults posted
• Clinical Trial of NAC in AsthmaTerminatedNCT02605824Phase 4Results posted
• A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic AsthmaCompletedNCT02596321Phase 3Results posted
• Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With AsthmaCompletedNCT02586506Phase 4Results posted
• Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild AsthmaCompletedNCT02584257Phase 3Results posted
• Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With AsthmaCompletedNCT02573233Phase 2Results posted
• Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD SubjectsCompletedNCT02573155Phase 1Results posted
• Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With AsthmaCompletedNCT02571777Phase 3Results posted
• Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute AsthmaCompletedNCT02566902Not applicableResults posted

← Asthma overview